A Study to Evaluate BMS-986470 in Healthy Volunteers and Participants With Sickle Cell Disease
Sickle cell disease is an inherited blood condition that can cause severe bouts of pain and anaemia. This study looks at an experimental medicine called BMS-986470. Researchers want to find out how safe the medicine is, how it moves through the body, and whether it could help reduce painful sickle cell episodes. The trial involves two main groups. First, healthy adult volunteers will take the medicine so researchers can check safety and see if food or common heartburn tablets affect absorption. Second, adults living with sickle cell disease who have frequent pain crises will take the study drug or a dummy pill (placebo). Taking part involves regular health reviews, blood tests, and clinic visits. This early-stage research is an essential step towards finding new treatments that may one day improve health and reduce hospital visits for people living with sickle cell disease.
במבט חטוף
על מה המחקר הזה?
Sickle cell disease is a lifelong genetic condition that affects red blood cells. Normally, red blood cells are round and flexible, allowing them to glide easily through blood vessels. In people with sickle cell disease, these cells can become hard and crescent-shaped. These rigid cells can get stuck in small blood vessels, blocking blood flow. This causes sudden, severe pain episodes known as vaso-occlusive crises, as well as fatigue and potential long-term damage to organs.
This clinical study is investigating a new tablet called BMS-986470. The primary goal is to find out if the drug is safe, how well the human body tolerates it, and how it is broken down. In the first stage, healthy volunteers will take the drug so doctors can observe how it behaves in the body and whether taking it with meals or standard antacid medicines changes how well it is absorbed.
In the next stage, the medicine will be given to adults who have sickle cell disease. Researchers want to observe whether BMS-986470 can help reduce the number of painful crises people experience and improve overall red blood cell health. Some participants may receive a placebo—a lookalike dummy pill with no active medicine—which helps doctors accurately compare the results.
Because this is an early-phase trial (Phase 1 and 2), the drug is not yet an approved treatment. However, well-monitored studies like this are crucial for creating newer, more effective treatment options for sickle cell disease in the future.
נקודות עיקריות
- The trial tests an experimental medicine (BMS-986470) designed to help treat sickle cell disease.
- It is recruiting healthy adult volunteers and adults living with sickle cell disease.
- Researchers are testing the drug's safety, absorption, and potential to reduce painful crises.
- Participation involves clinic visits, blood tests, health checks, and possible short clinic stays.
- Joining is completely voluntary, and you may leave the study at any time.
מי עשוי להיות זכאי?
This study is open to adults aged 18 and older, divided into two distinct groups. The first group is for healthy volunteers. To join this group, you must be in good general health, have a body mass index (BMI) between 18 and 32, and have no major health problems. Women joining the healthy group must not be able to have children (for instance, those who have gone through the menopause or had specific surgery).
The second group is for adults who have a confirmed medical diagnosis of sickle cell disease (such as HbSS or sickle beta-thalassaemia). To be considered, you must have experienced between 2 and 15 painful sickle cell crises over the past year that needed medical treatment. You must also be generally active and able to carry out daily tasks.
You will not be able to join the study if you have severe organ damage, recent major surgery, or blood test results that fall outside the trial's safety limits. A study doctor will run full health checks before confirming whether you can take part.
האם מחקר זה יכול להתאים לך?
ענה על השאלות המהירות הללו כדי לבדוק אם אתה עשוי להיות זכאי. זהו מדריך בלבד — צוות המחקר מקבל את ההחלטה הסופית.
- האם אתה בן 18 או יותר?
- Are you in good general health, OR do you have a confirmed diagnosis of sickle cell disease?
- If you have sickle cell, have you had at least 2 painful crises in the past year?
- Are you willing and able to attend clinic appointments and have regular blood tests?
- If female and in the healthy volunteer group, are you post-menopausal or unable to have children?
מה כרוך בהשתתפות?
If you decide to take part, you will first attend a screening visit. The team will ask about your medical history, carry out a physical examination, take blood samples, and perform heart traces (ECGs) to make sure it is safe for you to join. Depending on your group, you will take either BMS-986470, a placebo, or the study drug combined with common heartburn tablets to test how it is absorbed. You will need to attend regular clinic visits for blood tests and health check-ups. Some stages of the study may require a short overnight stay in a specialist clinic for close monitoring. The overall length of your participation will depend on which part of the study you join, but it typically lasts several weeks to months, followed by a final safety review.
סיכונים ותועלות פוטנציאליים
Locations (32)
- אוניברסיטת אלבמה בבירמינגהםמיקוד מאומתבירמינגהם, ארצות הברית· גיוס
- University of California San Diego - La Jollaמיקוד מאומתלה הויה, ארצות הברית· גיוס
- בית החולים לילדים UCSF בניוף אוקלנדמיקוד מאומתאוקלנד, ארצות הברית· גיוס
- Yale-New Haven Hospitalמיקוד מאומתניו הייבן, ארצות הברית· גיוס
- Winship Cancer Institute of Emory Universityמיקוד מאומתאטלנטה, ארצות הברית· גיוס
- מוסד מקומי - 0034מיקוד מאומתשיקגו, ארצות הברית· עדיין לא מגייסים
- מוסד מקומי - 0001מיקוד מאומתLenexa, United States· פעיל אך לא מגייס
- Local Institution - 0064מיקוד מאומתבולטימור, ארצות הברית· עדיין לא מגייסים
- Local Institution - 0024מיקוד מאומתבוסטון, ארצות הברית· עדיין לא מגייסים
- Boston Medical Centerמיקוד מאומתבוסטון, ארצות הברית· גיוס
- Local Institution - 0030מיקוד מאומתסנט לואיס, ארצות הברית· עדיין לא מגייסים
- Local Institution - 0033מיקוד מאומתגרינוויל, ארצות הברית· עדיין לא מגייסים
שאלות נפוצות
מהו פלצבו?
A placebo is a dummy treatment that looks and tastes identical to the real medicine but contains no active drug. It allows doctors to see if health changes are genuinely caused by the medicine being tested.
האם ההשתתפות תעלה לי משהו?
No, the study medicine and all trial-related tests are provided free of charge. Travel expenses are usually reimbursed, and healthy volunteers often receive compensation for their time.
Can I carry on taking my usual sickle cell medication?
Many participants can continue standard treatments like hydroxyurea, provided the dose has been stable for some time. The study doctor will check all your regular medicines to ensure they are safe to use together.
Do I have to stay overnight in hospital?
Some stages of this early study may require one or more overnight stays in a research clinic. This is so doctors can take timed blood tests and monitor your body's response safely.
האם אני יכול לעזוב את המחקר אם אשנה את דעתי?
Yes. You have the right to withdraw from the trial at any point, for any reason, without it affecting your normal medical care or your relationship with your doctors.
כיצד לגלות עוד
מרכז קשר לניסויים קליניים של BMS www.BMSClinicalTrials.com
תמיד התייעץ עם רופא המשפחה או המומחה שלך לפני שתחליט להשתתף במחקר.
מעוניינים להשתתף?
דיון
דיון קהילתי
מופעל על ידי הפורום שלנו ב community.patient.info. אנא היו מכבדים — זה אינו ייעוץ רפואי.